Rituximab maintenance treatment in patients with CD20+ B-cell non-Hodgkin's lymphoma

Trial Profile

Rituximab maintenance treatment in patients with CD20+ B-cell non-Hodgkin's lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2012

At a glance

  • Drugs Rituximab (Primary)
  • Indications B cell lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2012 Results for patients with diffuse large B-cell lymphoma presented at the 17th Congress of the European Haematology Association.
    • 13 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top